(redirected from Amarantus)
Also found in: Dictionary, Medical, Encyclopedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Words related to amaranth

References in periodicals archive ?
For current services performed FNMG has been compensated one thousand nine hundred dollars for news coverage of the current press release issued by Amarantus Bioscience Holdings, Inc.
This CRADA represents an important partnership for Amarantus as we work with the USAISR and Rutgers to advance the clinical program for ESS," said Gerald E.
RBCC and Amarantus expect to finalize NuroPro's development timeline within the next 12-14 months.
With this agreement, Amarantus has engaged Lonza via a long-term services agreement to manufacture ESS under Good Manufacturing Practices for human clinical trials, and subsequent commercial distribution.
RBCC and Amarantus finalized the framework of their proposed joint venture last week.
OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced Amarantus BioScience Holdings, Inc.
RBCC has also finalized joint venture terms with Amarantus BioSciences (OTCBB: AMBS), makers of a ground-breaking new blood-test diagnostic for Parkinson's disease.
Biotech & Pharma Companies in focus today from around the sector are: Amarantus BioScience Holdings, Inc.
Upon completing Phase 2, RBCC and Amarantus expect NuroPro to begin generating revenue through sales under a Clinical Laboratory Improvement Amendment (CLIA) certification.
com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks : Lifelogger (OTCMKTS:LOGG), Medical Marijuana (OTCMKTS:MJNA), TapImmune (OTCMKTS:TPIV), TOTALLY HEMP CRAZY (OTCMKTS:THCZ), AMARANTUS BIOSCI (OTCMKTS:AMBS), and Vapor Group (OTCMKTS:VPOR).
s (OTCBB:RBCC) biotech subsidiary, Rainbow BioSciences, nears a deal with Amarantus BioSciences (OTCBB: AMBS), the Alzheimer's epidemic is already drawing $100 million worth of disease research from big drug companies.
OTCBB: RBCC), announced today that it has prepared a joint venture term sheet for presentation to Amarantus BioSciences (OTCBB: AMBS), the makers of a revolutionary new diagnostic platform for Parkinson's disease.
OTCBB: RBCC) nears the completion of a ground-breaking joint venture agreement with Amarantus BioSciences (OTCBB: AMBS), the market demand for a cure to Parkinson's disease grows stronger by the day.